Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs
| Corporate συγγραφέας: | European Commission. |
|---|---|
| Μορφή: | Βιβλίο |
| Γλώσσα: | English |
| Στοιχεία έκδοσης: |
Luxembourg:
Office for Official Publications of the European Communities,
2002
|
| Ταξινομικός αριθμός: |
KET 615.3137 REP |
| Θέματα: | |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
| LEADER | 00769nam a2200193 4500 | ||
|---|---|---|---|
| 001 | 1/22524 | ||
| 008 | 030519s2002 lu a n001 0 eng | ||
| 020 | |a 9291681229 | ||
| 035 | |l 23893 | ||
| 040 | |a GR-PeUP | ||
| 082 | 0 | 0 | |a KET 615.3137 REP |
| 245 | 0 | 0 | |a Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs |
| 260 | |a Luxembourg: |b Office for Official Publications of the European Communities, |c 2002 | ||
| 300 | |a 92 σ.: |b εικ.; |c 21 εκ. | ||
| 650 | 4 | |a Gamma-hydroxybutyrate |z European Union countries. | |
| 650 | 4 | |a Drug abuse |z European Union countries. | |
| 650 | 4 | |a Drug monitoring |z European Union countries. | |
| 710 | 2 | |a European Commission. | |
| 852 | |a INST |b UNIPILB |c KET |e 20051024 |h KET 615.3137 REP |p 00144860 |q 00144860 |t LOAN |y 0 |4 1 | ||